Risk factors for visual field progression in treated glaucoma

Carlos Gustavo V De Moraes, Viral V. Juthani, Jeffrey M. Liebmann, Christopher C. Teng, Celso Tello, Remo Susanna, Robert Ritch

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

Objective: To determine intraocular pressure (IOP)-dependent and IOP-independent variables associated with visual field (VF) progression in treated glaucoma. Design: Retrospective cohort of the Glaucoma Progression Study. Methods: Consecutive, treated glaucoma patients with repeatable VF loss who had 8 or more VF examinations of either eye, using the Swedish Interactive Threshold Algorithm (24-2 SITA-Standard, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc, Dublin, California), during the period between January 1999 and September 2009 were included. Visual field progression was evaluated using automated pointwise linear regression. Evaluated data included age, sex, race, central corneal thickness, baseline VF mean deviation, mean follow-up IOP, peak IOP, IOP fluctuation, a detected disc hemorrhage, and presence of beta-zone parapapillary atrophy. Results: We selected 587 eyes of 587 patients (mean [SD] age, 64.9 [13.0] years). The mean (SD) number of VFs was 11.1 (3.0), spanning a mean (SD) of 6.4 (1.7) years. In the univariable model, older age (odds ratio [OR], 1.19 per decade; P=.01), baseline diagnosis of exfoliation syndrome (OR, 1.79; P=.01), decreased central corneal thickness (OR, 1.38 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.31; P < .01), presence of betazone parapapillary atrophy (OR, 2.17; P < .01), and all IOP parameters (mean follow-up, peak, and fluctuation; P < .01) were associated with increased risk of VF progression. In the multivariable model, peak IOP (OR, 1.13; P < .01), thinner central corneal thickness (OR, 1.45 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.59; P < .01), and presence of beta-zone parapapillary atrophy (OR, 2.38; P<.01) were associated with VF progression. Conclusions: IOP-dependent and IOP-independent risk factors affect disease progression in treated glaucoma. Peak IOP is a better predictor of progression than is IOP mean or fluctuation.

Original languageEnglish (US)
Pages (from-to)562-568
Number of pages7
JournalArchives of Ophthalmology
Volume129
Issue number5
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Visual Fields
Intraocular Pressure
Glaucoma
Odds Ratio
Atrophy
Hemorrhage
Exfoliation Syndrome
Disease Progression
Linear Models

ASJC Scopus subject areas

  • Ophthalmology

Cite this

De Moraes, C. G. V., Juthani, V. V., Liebmann, J. M., Teng, C. C., Tello, C., Susanna, R., & Ritch, R. (2011). Risk factors for visual field progression in treated glaucoma. Archives of Ophthalmology, 129(5), 562-568. https://doi.org/10.1001/archophthalmol.2011.72

Risk factors for visual field progression in treated glaucoma. / De Moraes, Carlos Gustavo V; Juthani, Viral V.; Liebmann, Jeffrey M.; Teng, Christopher C.; Tello, Celso; Susanna, Remo; Ritch, Robert.

In: Archives of Ophthalmology, Vol. 129, No. 5, 05.2011, p. 562-568.

Research output: Contribution to journalArticle

De Moraes, CGV, Juthani, VV, Liebmann, JM, Teng, CC, Tello, C, Susanna, R & Ritch, R 2011, 'Risk factors for visual field progression in treated glaucoma', Archives of Ophthalmology, vol. 129, no. 5, pp. 562-568. https://doi.org/10.1001/archophthalmol.2011.72
De Moraes, Carlos Gustavo V ; Juthani, Viral V. ; Liebmann, Jeffrey M. ; Teng, Christopher C. ; Tello, Celso ; Susanna, Remo ; Ritch, Robert. / Risk factors for visual field progression in treated glaucoma. In: Archives of Ophthalmology. 2011 ; Vol. 129, No. 5. pp. 562-568.
@article{7945d95cbd6940b9a4b59a05a0b8633c,
title = "Risk factors for visual field progression in treated glaucoma",
abstract = "Objective: To determine intraocular pressure (IOP)-dependent and IOP-independent variables associated with visual field (VF) progression in treated glaucoma. Design: Retrospective cohort of the Glaucoma Progression Study. Methods: Consecutive, treated glaucoma patients with repeatable VF loss who had 8 or more VF examinations of either eye, using the Swedish Interactive Threshold Algorithm (24-2 SITA-Standard, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc, Dublin, California), during the period between January 1999 and September 2009 were included. Visual field progression was evaluated using automated pointwise linear regression. Evaluated data included age, sex, race, central corneal thickness, baseline VF mean deviation, mean follow-up IOP, peak IOP, IOP fluctuation, a detected disc hemorrhage, and presence of beta-zone parapapillary atrophy. Results: We selected 587 eyes of 587 patients (mean [SD] age, 64.9 [13.0] years). The mean (SD) number of VFs was 11.1 (3.0), spanning a mean (SD) of 6.4 (1.7) years. In the univariable model, older age (odds ratio [OR], 1.19 per decade; P=.01), baseline diagnosis of exfoliation syndrome (OR, 1.79; P=.01), decreased central corneal thickness (OR, 1.38 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.31; P < .01), presence of betazone parapapillary atrophy (OR, 2.17; P < .01), and all IOP parameters (mean follow-up, peak, and fluctuation; P < .01) were associated with increased risk of VF progression. In the multivariable model, peak IOP (OR, 1.13; P < .01), thinner central corneal thickness (OR, 1.45 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.59; P < .01), and presence of beta-zone parapapillary atrophy (OR, 2.38; P<.01) were associated with VF progression. Conclusions: IOP-dependent and IOP-independent risk factors affect disease progression in treated glaucoma. Peak IOP is a better predictor of progression than is IOP mean or fluctuation.",
author = "{De Moraes}, {Carlos Gustavo V} and Juthani, {Viral V.} and Liebmann, {Jeffrey M.} and Teng, {Christopher C.} and Celso Tello and Remo Susanna and Robert Ritch",
year = "2011",
month = "5",
doi = "10.1001/archophthalmol.2011.72",
language = "English (US)",
volume = "129",
pages = "562--568",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Risk factors for visual field progression in treated glaucoma

AU - De Moraes, Carlos Gustavo V

AU - Juthani, Viral V.

AU - Liebmann, Jeffrey M.

AU - Teng, Christopher C.

AU - Tello, Celso

AU - Susanna, Remo

AU - Ritch, Robert

PY - 2011/5

Y1 - 2011/5

N2 - Objective: To determine intraocular pressure (IOP)-dependent and IOP-independent variables associated with visual field (VF) progression in treated glaucoma. Design: Retrospective cohort of the Glaucoma Progression Study. Methods: Consecutive, treated glaucoma patients with repeatable VF loss who had 8 or more VF examinations of either eye, using the Swedish Interactive Threshold Algorithm (24-2 SITA-Standard, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc, Dublin, California), during the period between January 1999 and September 2009 were included. Visual field progression was evaluated using automated pointwise linear regression. Evaluated data included age, sex, race, central corneal thickness, baseline VF mean deviation, mean follow-up IOP, peak IOP, IOP fluctuation, a detected disc hemorrhage, and presence of beta-zone parapapillary atrophy. Results: We selected 587 eyes of 587 patients (mean [SD] age, 64.9 [13.0] years). The mean (SD) number of VFs was 11.1 (3.0), spanning a mean (SD) of 6.4 (1.7) years. In the univariable model, older age (odds ratio [OR], 1.19 per decade; P=.01), baseline diagnosis of exfoliation syndrome (OR, 1.79; P=.01), decreased central corneal thickness (OR, 1.38 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.31; P < .01), presence of betazone parapapillary atrophy (OR, 2.17; P < .01), and all IOP parameters (mean follow-up, peak, and fluctuation; P < .01) were associated with increased risk of VF progression. In the multivariable model, peak IOP (OR, 1.13; P < .01), thinner central corneal thickness (OR, 1.45 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.59; P < .01), and presence of beta-zone parapapillary atrophy (OR, 2.38; P<.01) were associated with VF progression. Conclusions: IOP-dependent and IOP-independent risk factors affect disease progression in treated glaucoma. Peak IOP is a better predictor of progression than is IOP mean or fluctuation.

AB - Objective: To determine intraocular pressure (IOP)-dependent and IOP-independent variables associated with visual field (VF) progression in treated glaucoma. Design: Retrospective cohort of the Glaucoma Progression Study. Methods: Consecutive, treated glaucoma patients with repeatable VF loss who had 8 or more VF examinations of either eye, using the Swedish Interactive Threshold Algorithm (24-2 SITA-Standard, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc, Dublin, California), during the period between January 1999 and September 2009 were included. Visual field progression was evaluated using automated pointwise linear regression. Evaluated data included age, sex, race, central corneal thickness, baseline VF mean deviation, mean follow-up IOP, peak IOP, IOP fluctuation, a detected disc hemorrhage, and presence of beta-zone parapapillary atrophy. Results: We selected 587 eyes of 587 patients (mean [SD] age, 64.9 [13.0] years). The mean (SD) number of VFs was 11.1 (3.0), spanning a mean (SD) of 6.4 (1.7) years. In the univariable model, older age (odds ratio [OR], 1.19 per decade; P=.01), baseline diagnosis of exfoliation syndrome (OR, 1.79; P=.01), decreased central corneal thickness (OR, 1.38 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.31; P < .01), presence of betazone parapapillary atrophy (OR, 2.17; P < .01), and all IOP parameters (mean follow-up, peak, and fluctuation; P < .01) were associated with increased risk of VF progression. In the multivariable model, peak IOP (OR, 1.13; P < .01), thinner central corneal thickness (OR, 1.45 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.59; P < .01), and presence of beta-zone parapapillary atrophy (OR, 2.38; P<.01) were associated with VF progression. Conclusions: IOP-dependent and IOP-independent risk factors affect disease progression in treated glaucoma. Peak IOP is a better predictor of progression than is IOP mean or fluctuation.

UR - http://www.scopus.com/inward/record.url?scp=79955757915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955757915&partnerID=8YFLogxK

U2 - 10.1001/archophthalmol.2011.72

DO - 10.1001/archophthalmol.2011.72

M3 - Article

C2 - 21555607

AN - SCOPUS:79955757915

VL - 129

SP - 562

EP - 568

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -